Credelio 48mg Chewable Tablets for Cats Pack of 6

Credelio 48mg Chewable Tablets for Cats work rapidly to kill fleas and ticks, providing immediate and persistent protection for one month. The active ingredient, lotilaner, begins to work quickly, effectively breaking the flea life cycle by killing fleas before they can lay eggs, preventing environmental contamination.

Effective Parasite Control for Your Cat

This veterinary medicinal product is an excellent choice for comprehensive parasite management, including as part of a treatment strategy for the control of flea allergy dermatitis (FAD). Its persistent killing activity ensures continuous protection, helping to keep your cat comfortable and healthy.

Why Choose Credelio for Your Cat?

• Rapid Action: Kills existing fleas within 8 hours and ticks within 18 hours of administration.
• Long-lasting Protection: Provides immediate and persistent killing activity for a full month.
• Easy to Administer: Chewable tablets can be given with food or within 30 minutes after feeding, making it simple to ensure your cat takes their dose.
• Breaks Life Cycle: Kills fleas before they lay eggs, helping to prevent re-infestation of your home.
• Suitable for Cats: Specifically designed for cats weighing between 2.0 kg and 8.0 kg.

At Weldricks Pharmacy, we are committed to providing trustworthy and affordable healthcare solutions for your entire family, including your beloved pets. Choose Credelio 48mg Chewable Tablets for Cats for reliable, stress-free flea and tick prevention.

For oral use.

Administer the Credelio 48mg Chewable Tablets for Cats with food or within 30 minutes after feeding.

The flavoured veterinary medicinal product should be administered in accordance with the following table to ensure a single dose of 6 to 24 mg lotilaner/kg bodyweight:

For cats of more than 8 kg body weight use an appropriate combination of available strengths to achieve the recommended dose of 6 – 24 mg/kg.

For optimal control of tick and flea infestations, the veterinary medicinal product should be administered at monthly intervals and continued throughout the flea and/or tick season based on local epidemiological situations.

Contraindications:

• Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

Special warnings for safe use in the target species:

• Parasites need to start feeding on the host to become exposed to lotilaner; therefore, the risk of the transmission of parasite borne diseases cannot be completely excluded.
• Acceptable levels of efficacy may not be achieved if the veterinary medicinal product is not administered with food or within 30 minutes after feeding.
• Due to insufficient data to support efficacy against ticks in young cats, this product is not recommended for the treatment of ticks in kittens 5 months of age or younger.
• All safety and efficacy data have been acquired from cats and kittens 8 weeks of age and older and 0.5 kg of body weight and greater. Use of this veterinary medicinal product in kittens younger than 8 weeks of age or less than 0.5 kg of body weight should be based on a benefit-risk assessment by the responsible veterinarian.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:

• Wash hands after handling the product.
• In case of accidental ingestion, seek medical advice immediately and show the package leaflet or label to the physician.

Pregnancy and lactation:

• Laboratory studies in rats have not produced any evidence of teratogenic effects.
• The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only according to the benefit/risk assessment by the responsible veterinarian.

Fertility:

• Laboratory studies in rats have not produced any evidence of any adverse effect on the reproductive capacity of males and females.
• The safety of the veterinary medicinal product in breeding queens has not been established. Use only according to the benefit/risk assessment by the responsible veterinarian.

Interaction with other medicinal products and other forms of interaction:

• None known. During clinical testing, no interactions between Credelio chewable tablets and routinely used veterinary medicinal products were observed.

Adverse Events (Very rare <1 animal / 10,000 animals treated, including isolated reports):

• Hyperactivity
• Vomiting
• Ataxia (incoordination)
• Muscle tremor
• Tachypnoea (rapid shallow breathing)
• Pruritus (itching)
• Anorexia (loss of appetite)
• Lethargy

Special Storage Precautions:

• Keep out of the sight and reach of children.
• Keep the blister pack in the outer carton.
• This veterinary medicinal product does not require any special storage conditions.
• Do not use this veterinary medicinal product after the expiry date which is stated on the carton and blister after Exp. The expiry date refers to the last day of that month.

Special precautions for the disposal of unused products or waste materials:

• Medicines should not be disposed of via wastewater.
• Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
• Ask your veterinary surgeon or pharmacist how to dispose of medicines no longer required. These measures should help to protect the environment.

Each Credelio 48mg chewable tablet contains:

• Active substance: 48 mg lotilaner